Fortress Biotech, Inc. (FBIO): Price and Financial Metrics

Fortress Biotech, Inc. (FBIO): $3.07

-0.09 (-2.85%)

POWR Rating

Component Grades













Add FBIO to Watchlist
Sign Up

Industry: Biotech


of 498

in industry


  • Sentiment is the dimension where FBIO ranks best; there it ranks ahead of 90.36% of US stocks.
  • FBIO's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • FBIO ranks lowest in Momentum; there it ranks in the 5th percentile.

FBIO Stock Summary

  • Of note is the ratio of Fortress Biotech Inc's sales and general administrative expense to its total operating expenses; 25.57% of US stocks have a lower such ratio.
  • FBIO's price/sales ratio is 7.06; that's higher than the P/S ratio of 75.38% of US stocks.
  • With a year-over-year growth in debt of -21.3%, Fortress Biotech Inc's debt growth rate surpasses merely 22.78% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Fortress Biotech Inc, a group of peers worth examining would be PTCT, CHRS, CREX, GPL, and INFN.
  • Visit FBIO's SEC page to see the company's official filings. To visit the company's web site, go to

FBIO Valuation Summary

  • In comparison to the median Healthcare stock, FBIO's price/sales ratio is 86.11% higher, now standing at 6.7.
  • Over the past 118 months, FBIO's price/earnings ratio has gone up 0.8.
  • FBIO's price/sales ratio has moved NA NA over the prior 118 months.

Below are key valuation metrics over time for FBIO.

Stock Date P/S P/B P/E EV/EBIT
FBIO 2020-12-11 5.5 2.4 -4.2 -2.3
FBIO 2018-03-22 1.4 5.0 -4.0 -3.4
FBIO 2015-01-29 NA 1.5 -3.9 -1.3
FBIO 2014-04-22 NA 1.0 -2.3 0.0
FBIO 2014-04-17 NA 1.0 -2.1 0.2
FBIO 2013-05-08 NA 11.2 -8.9 -8.2

FBIO Growth Metrics

  • Its 4 year price growth rate is now at -12%.
  • Its 4 year net income to common stockholders growth rate is now at -10.59%.
  • The 2 year cash and equivalents growth rate now stands at 7.86%.
FBIO's revenue has moved down $184,003,000 over the prior 30 months.

The table below shows FBIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 44.268 -83.478 -42.978
2020-12-31 45.599 -83.682 -46.526
2020-12-31 45.599 -83.682 -46.526
2020-09-30 42.98 -88.248 -56.723
2020-06-30 43.277 -80.62 -53.938
2020-03-31 43.07 -91.528 -53.722

FBIO Price Target

For more insight on analysts targets of FBIO, see our FBIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.17 Average Broker Recommendation 1.5 (Moderate Buy)

FBIO Stock Price Chart Interactive Chart >

Price chart for FBIO

FBIO Price/Volume Stats

Current price $3.07 52-week high $6.10
Prev. close $3.16 52-week low $2.12
Day low $3.06 Volume 116,602
Day high $3.17 Avg. volume 1,203,375
50-day MA $3.59 Dividend yield N/A
200-day MA $3.50 Market Cap 298.77M

Fortress Biotech, Inc. (FBIO) Company Bio

Fortress Biotech, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. The company was founded in 2006 and is based in New York, New York.

FBIO Latest News Stream

Event/Time News Detail
Loading, please wait...

FBIO Latest Social Stream

Loading social stream, please wait...

View Full FBIO Social Stream

Latest FBIO News From Around the Web

Below are the latest news stories about Fortress Biotech Inc that investors may wish to consider to help them evaluate FBIO as an investment opportunity.

Fortress Biotech, Inc. (NASDAQ:FBIO): Are Analysts Optimistic?

Fortress Biotech, Inc. ( NASDAQ:FBIO ) is possibly approaching a major achievement in its business, so we would like to...

Yahoo | July 15, 2021

Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference

NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in the Ladenburg Thalmann 2021 Healthcare Conference, taking place July 13-14, 2021. The company will present a corporate update on Wednesday, July 14, 2021, at 11:30 a.m. ET and will also participate in one-on-one meetings during the confe

Yahoo | July 8, 2021

Journey Medical Partners Dr. Reddy''s To Develop DFD-29 To Treat Rosacea

NEW DELHI (dpa-AFX) - Journey Medical Corp., a partner company of biopharmaceutical company Fortress Biotech, Inc. (FBIO), announced Wednesday an agreement with India-based pharmaceutical company

FinanzNachrichten | June 30, 2021

Journey Medical Partners Dr. Reddy''s To Develop DFD-29 To Treat Rosacea - Quick Facts

(RTTNews) - Journey Medical Corp., a partner company of biopharmaceutical company Fortress Biotech, Inc. (FBIO), announced Wednesday an agreement with India-based pharmaceutical company Dr. Reddy''s Laboratories Ltd. (RDY) for the collaborative development and commercialization of the DFD-29 program (Minocycline Modified Release Capsules 40 mg)

Business Insider Markets | June 30, 2021

Dr. Reddy''s Lab, Fortress Biotech Ink DFD-29 Collaboration Pact For Chronic Skin Disorder

Journey Medical Corporation , a partner company of Fortress Biotech Inc (NASDAQ: FBIO ), has entered into a collaborative development and commercialization agreement with Dr. Reddy''s Laboratories Ltd (NYSE: RDY ) for the DFD-29 (Minocycline Modified Release Capsules 40 mg) for the treatment of rosacea. Journey Medical has acquired global commercialization rights, including the Full story available on

Benzinga | June 30, 2021

Read More 'FBIO' Stories Here

FBIO Price Returns

1-mo -14.01%
3-mo -28.94%
6-mo -3.76%
1-year 10.43%
3-year 37.67%
5-year 1.32%
YTD -3.15%
2020 23.35%
2019 198.84%
2018 -78.45%
2017 47.78%
2016 -3.23%

Continue Researching FBIO

Here are a few links from around the web to help you further your research on Fortress Biotech Inc's stock as an investment opportunity:

Fortress Biotech Inc (FBIO) Stock Price | Nasdaq
Fortress Biotech Inc (FBIO) Stock Quote, History and News - Yahoo Finance
Fortress Biotech Inc (FBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9587 seconds.